Below are the financial statements of Apellis Pharmaceuticals, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Product revenue, net | 709.95a | 366.28a | 65.09a |
| Licensing and other revenue | 71.41a | 30.31a | 10.33a |
| Total revenue | 781.37a | 396.59a | 75.42a |
| Operating expenses | — | — | — |
| Cost of sales | -117.72a | -58.51a | -5.64a |
| Research and development | -327.57a | -354.39a | -387.24a |
| Selling, general and administrative | -501.05a | -500.82a | -277.16a |
| Total operating expenses | -946.35a | -913.71a | -670.04a |
| Net operating loss | -164.98a | -517.12a | -594.61a |
| Loss on conversion of debt | 0a | 0a | -32.89a |
| Loss on extinguishment of development liability | -1.95a | 0a | 0a |
| Interest income | 12.77a | 20.93a | 8.91a |
| Interest expense | -40.39a | -29.58a | -32.63a |
| Other expense, net | -2.17a | -0.73a | -0.29a |
| Net loss before taxes | -196.72a | -526.5a | -651.5a |
| Income tax expense | -1.16a | -2.13a | -0.67a |
| Net loss | -197.88a | -528.63a | -652.17a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Apellis Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.